German MDx Firm Mainz Biomed Raises $10M in IPO, Begins Trading on Nasdaq - NewsBreak Home > Business > Article
2 years ago By Bryan — NEW YORK – Mainz Biomed, a German molecular diagnostics company developing tests for the early detection of cancer, said on Monday that its shares have sta
#germanmdxfirmmainzbiomed #ipo #nasdaq